[如何解释心血管试验中的子组分析?]
Christian Basile1, Aldo Pietro Maggioni2
1Division of Cardiology, Department of Medicine, Karolinska Institutet, Stoccolma, Svezia - Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli "Federico II", Napoli.
Giornale italiano di cardiologia (2006)
|June 25, 2024
概括
临床试验中的子组分析检查了不同患者群体的治疗效果. 本综述为心血管研究中解释这些分析提供了批判性的方法,强调先验定义和统计能力.
科学领域:
- 心血管医学 心血管医学
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
背景情况:
- 临床试验评估整体人群的治疗疗效,通常假设在患者子组之间具有统一的效果.
- 小组分析对于理解基于患者特征 (年龄,性别等) 的治疗效果变异性至关重要. ) 的情况.
- 这些分析解决了有关特定亚群的治疗决策和益处/风险概况的实际问题.
研究的目的:
- 为心血管临床试验中解释子组分析提出一个关键框架.
- 要强调先验定义,生物可信性和子组分析的有限范围的重要性.
- 引导研究人员评估子组发现的可信性和影响,特别是中立或负面的整体研究.
主要方法:
- 审查临床研究中进行和解释子组分析的原则和最佳实践.
- 强调先验和后期小组分析之间的区别.
- 讨论在特定患者子组预期异质性时的统计功率要求.
主要成果:
- 当总体试验结果显示出显著的治疗差异时,子组分析最相关.
- 中性或负性试验中的重大发现应被视为探索性.
- 后期小组分析需要谨慎的解释和外部的一致性,以获得可信度.
结论:
- 在心血管试验中解释子组分析时,需要采用结构化,批判性的方法.
- 坚持预先定义的,生物学上可信的假设提高了子组发现的有效性.
- 充分的统计能力对于子组分析至关重要,特别是当预计治疗效果异质时.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:50Statistical Significance
20.1K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
20.1K
01:12Hazard Ratio
111
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
111
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.3K